Cite Filings / NAMS
Feed Companies Filings Check
Sign in

CIK 0001936258

  • Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
Filings Financials Insiders Search text
All 417 Financials 62 Shareholder Meetings 6 Executive Compensation 56 Insider Trading 132 Beneficial Ownership Interest 48 Business Combinations 76 Public Offerings 44 Foreign Private Issuers 32 Mutual Funds and ETFs 3 Others 70
›
Filed in
  1. No filings match these filters. Clear filters
  2. 3 Insider Initial Statement of Ownership 2023-12-29
  3. 3 Insider Initial Statement of Ownership 2023-12-29
  4. 3 Insider Initial Statement of Ownership 2023-12-29
  5. 3 Insider Initial Statement of Ownership 2023-12-29
  6. 3 Insider Initial Statement of Ownership 2023-12-29
  7. 3 Insider Initial Statement of Ownership 2023-12-29
  8. 3 Insider Initial Statement of Ownership 2023-12-29
  9. 3 Insider Initial Statement of Ownership 2023-12-29
  10. 3 Insider Initial Statement of Ownership 2023-12-29
  11. 3 Insider Initial Statement of Ownership 2023-12-29
  12. 3 Insider Initial Statement of Ownership 2023-12-29
  13. 3 Insider Initial Statement of Ownership 2023-12-29

Page 7 of 7 · 132 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…